Alexza Pharmaceuticals Inc. (ALXA) halted, news pending
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alexza Pharma (ALXA) Receives Positive Opinion on ADASUVE from CHMP
December 14, 2012 8:09 AM ESTAlexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending that ADASUVE (Staccato loxapine) be granted European Union (EU) centralized marketing... More
Alexza Pharma (ALXA) Short Interest Rises into Adasuve Panel Vote
December 14, 2012 7:20 AM ESTAlexza Pharmaceuticals (Nasdaq: ALXA) is currently halted following the EMA issuing a positive recommendation for Adasuve.
Traders might want to brace for quite a ride. Short interest is 2,421,339 as of November 30th, or about 16.4 percent of float. The number is up from 2,176,336 at... More
EMA issues positive recommendation for Alexza's (ALXA) Adasuve
December 14, 2012 7:14 AM ESTEMA issues positive recommendation for Alexza Pharmaceuticals' (NASDAQ: ALXA) Adasuve. (note: Shares currently halted)... More
